These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9700880)

  • 1. [Evaluation of the effectiveness of influenza trivalent polymer subunit vaccine "Grippol"].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Pavlova LI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Belashev VP; Malinovskiĭ AA
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (3):40-3. PubMed ID: 9700880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer-subunit influenza vaccine administered to schoolchildren].
    El'shina GA; Gorbunov MA; Bektimirov TA; Lonskaia NI; Pavlova LI; Nikul'shin AA; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):50-4. PubMed ID: 10808574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prophylactic efficacy of the trivalent polymer-subunit influenza vaccine Grippol (3)].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Pavlova LI; Malinovskiĭ AA
    Voen Med Zh; 1997 Feb; 318(2):47-9. PubMed ID: 9148581
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epidemiological and economic effectiveness of immunization of adult and children against influenza and acute respiratory viral infections with the vaccine Grippol].
    Khaitov RM; Nekrasov AV; Puchkova NG; Ivanova AS
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (3):83-6. PubMed ID: 12886641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The trivalent polymer-subunit influenza vaccine Grippol studied in a controlled epidemiological trial (1)].
    El'shina GA; Masalin IuM; Shervali VI; Gorbunov MA; Lonskaia NI; Agafonova LV; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG
    Voen Med Zh; 1996 Aug; 317(8):57-60. PubMed ID: 9036650
    [No Abstract]   [Full Text] [Related]  

  • 6. [The antigenic-immunogenic activity of the trivalent polymer-subunit influenza vaccine Grippol in a controlled epidemiological trial (2)].
    El'shina GA; Masalin IuM; Shervarli VI; Gorbunov MA; Lonskaia NI; Agafonova LV; Khaitov RM; Nekrasov AV; Ivanova AS
    Voen Med Zh; 1996 Nov; 317(11):53-5. PubMed ID: 9036633
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of the reactogenicity and immunogenicity of inactivated influenza vaccines in the elderly].
    Burtseva EI; Slepushkin AN; Vlasova LN; Oskerko TA; Fedorova GI; Stepnova AI; Beregovskiĭ NA
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):40-5. PubMed ID: 11220963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dynamics of autoantibodies in elderly persons in the process of vaccination with Grippol and multicomponent vaccine VP-4].
    Egorova NB; Semenov BF; Kurbatova EA; Iastrebova NE; Poddubikov AV; Efremova VN; Semenova IB
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (5):29-35. PubMed ID: 12524997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of mass influenza prevention effectiveness using an inactivated chromatographic vaccine in Leningrad].
    Ivannikov IuG; Efimenko IB; Marinich IG; Luk'ianov IuV; Naĭkhin AN
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Nov; (11):18-27. PubMed ID: 6449811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunostimulating activity of polycomponent vaccine "Immunovac-VP-4" and grippol after their combined administration].
    Kurbatova EA; Semenov BF; Egorova NB; Efremova VN; Gruber IM; Semenova IB; Kushchenko OM
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):34-9. PubMed ID: 15346947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluarix quadrivalent vaccine for influenza.
    Graaf Hd; Faust SN
    Expert Rev Vaccines; 2015; 14(8):1055-63. PubMed ID: 26098443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effectiveness of using the Vaxigrip vaccine from the firm of Pasteur Mérieux Connaught for influenza prevention in organized groups of adults].
    Sharipova IS; Fel'dblium IV; Kuz'minykh SI; Nikolova IV; Padrul' MM; Sharipov MS; Nikul'shin AA; Kol'tsova AA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):37-41. PubMed ID: 10851988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak.
    Gravenstein S; Drinka P; Duthie EH; Miller BA; Brown CS; Hensley M; Circo R; Langer E; Ershler WB
    J Am Geriatr Soc; 1994 Mar; 42(3):245-51. PubMed ID: 8120307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of influenza vaccine Vaxigrip in the combined immunization of conscripts during influenza seasons of 2002-2003].
    Burtseva EI; Vlasova LN; Shevchenko ES; Sabanin IuV; Rikhter VV; Artiukov RM; Rybin VV; Tarasevich NN; Slepushkin AN
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (1):49-55. PubMed ID: 15024982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study.
    Savulescu C; Jiménez-Jorge S; de Mateo S; Ledesma J; Pozo F; Casas I; Larrauri A;
    Euro Surveill; 2011 Mar; 16(11):. PubMed ID: 21435330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenicity and the protective effectiveness of the subunit trivalent influenza vaccine Grippovac].
    Chumakov MP; Malyshkina LP; Mart'ianova LI; Marinina VP; Mel'nikova SK
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Feb; (2):44-9. PubMed ID: 2938372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The evaluation of the epidemiological efficacy of 3-component inactivated influenza vaccines using an intranasal application method].
    Marinich IG; Iaroshevskaia IIu; Konareva AL; Lonskaia NI; Shadrin AS; Salmin LV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):76-8. PubMed ID: 8079581
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.